Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.
Notice for zongertinib (Boehringer Ingelheim Pty Ltd)
Active ingredients
zongertinib
Sponsor
Date of review outcome
Lapse date
Type
Provisional determination
Therapeutic area
Oncology